Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

202
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
202
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.1K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

541
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
541
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

830
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
830

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Current status and problems of the entirely subcutaneous ICD (S-ICD®)].

Herzschrittmachertherapie & Elektrophysiologie·2013
Same author

[A concept to improve wet-lab training in ENT surgery].

Laryngo- rhino- otologie·2012
Same author

Pulmonary Palacos embolism: a case report.

The Thoracic and cardiovascular surgeon·2010
Same author

Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure.

The Thoracic and cardiovascular surgeon·2010
Same author

German disease management guidelines: surgical therapies for chronic heart failure.

The Thoracic and cardiovascular surgeon·2010
Same author

Limitations of high urgency listing--ventricular assist device support in a neonate for 452 days.

The Thoracic and cardiovascular surgeon·2010
Same journal

[Reorientation of the hospital planning in NRW-Importance for cardiovascular medicine and thoracic surgery].

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2023
Same journal

[Pulmonary embolism].

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2023
Same journal

[Back to the future?]

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2023
Same journal

[Social media, are they necessary?]

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2023
Same journal

[Operating during pregnancy].

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2022
Same journal

[Impact of the COVID-19 pandemic on cardiac surgery].

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2022
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K

[Off-label use in cardiac surgery].

H Fenger1, A Löher2, J R Sindermann2

  • 1Rechtsanwalt und Notar, Kanzlei Möller/Post/Fenger, Frauenstr. 31, 48143 Münster, Deutschland.

Zeitschrift Fur Herz-, Thorax- Und Gefasschirurgie
|April 15, 2020
PubMed
Summary
This summary is machine-generated.

Informed consent is crucial for off-label drug use, emphasizing the treatment's experimental nature and associated risks. Documenting patient understanding and outlining differences from standard care are essential steps.

Keywords:
Cardiac surgeryLegal aspectsOff-label use

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K
Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.9K

Related Experiment Videos

Last Updated: Dec 24, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K
Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.9K

Area of Science:

  • Medical Ethics
  • Pharmacology
  • Clinical Trials

Context:

  • Off-label drug use presents unique ethical challenges.
  • Standard treatment protocols may not apply.
  • Patient safety and autonomy are paramount.

Purpose:

  • To highlight the critical need for informed consent in off-label treatment scenarios.
  • To outline the essential components of documenting informed consent for unapproved drug use.

Summary:

  • Obtaining informed consent requires clearly communicating the experimental nature of off-label treatments.
  • Patients must be fully apprised of potential risks associated with using drugs not approved for their condition.
  • Documentation should detail the differences between the proposed off-label treatment and standard therapeutic options.

Impact:

  • Ensures patient autonomy and understanding in non-standard medical care.
  • Establishes a clear ethical and legal framework for off-label prescribing.
  • Promotes transparency and trust between healthcare providers and patients.